PROCEPT BioRobotics Corp. (NASDAQ:PRCT) shares are down during Thursday’s premarket session following the company’s recent financial results and updates on its revenue guidance.Performance MetricsIn its fourth quarter of 2025, PROCEPT BioRobotics reported total revenue of $76.4 million, marking a 12% increase compared to the prior year, missing the consensus of $94.14 million. The increase was primarily driven by increased handpiece revenue.U.S. handpiece and consumable revenue was $34.0 million, an increas ...